Safety and efficacy of COVID‐19 vaccines: A systematic review and meta‐analysis of controlled and randomized clinical trials

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817 · see citing works

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592 · cited 6× · see citing works

mRNA vaccines — a new era in vaccinology

Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667 · see citing works

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32661-1 · Cited by 4,616 · see citing works

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Sadoff, J., Gray, G., Vandebosch, A., Cárdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Fennema, H., Spiessens, B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101544 · Cited by 2,397 · see citing works

SARS-CoV-2 vaccines in development

Krammer, F. (2020) · Nature · doi:10.1038/s41586-020-2798-3 · Cited by 2,098 · see citing works

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

Watson, O. J., Barnsley, G., Toor, J., Hogan, A. B., Winskill, P., & Ghani, A. C. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00320-6 · Cited by 1,769 · see citing works

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

Thomas, S. J., Moreira, E. D., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Polack, F. P., Zerbini, C., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2110345 · Cited by 1,640 · see citing works

A guide to vaccinology: from basic principles to new developments

Pollard, A. J., & Bijker, E. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00479-7 · Cited by 1,593 · see citing works

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

Madhi, S. A., Baillie, V., Cutland, C. L., Voysey, M., Koen, A. L., Fairlie, L., Padayachee, S. D., Dheda, K., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2102214 · Cited by 1,257 · see citing works

Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine

Heath, P. T., Galiza, E. P., Baxter, D. N., Boffito, M., Browne, D., Burns, F., Chadwick, D. R., Clark, R., Cosgrove, C., Galloway, J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107659 · Cited by 1,085 · see citing works

Immunological considerations for COVID-19 vaccine strategies

Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00434-6 · Cited by 1,015 · see citing works

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

Tanriover, M. D., Doğanay, H. L., Akova, M., Güner, H. R., Azap, A., Akhan, S., Köse, Ş., Erdinç, F. Ş., Akalın, E. H., Tabak, Ö. F., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01429-x · Cited by 898 · see citing works

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Wang, H., Zhang, Y., Huang, B., Deng, W., Quan, Y., Wang, W., Xu, W., Zhao, Y., Li, N., Zhang, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.008 · Cited by 748 · see citing works

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

Falsey, A. R., Sobieszczyk, M. E., Hirsch, I., Sproule, S., Robb, M. L., Corey, L., Neuzil, K. M., Hahn, W., Hunt, J., Mulligan, M. J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2105290 · Cited by 670 · see citing works

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

El Sahly, H. M., Baden, L. R., Essink, B., Doblecki-Lewis, S., Martin, J. M., Anderson, E. J., Campbell, T. B., Clark, J., Jackson, L. A., Fichtenbaum, C. J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2113017 · Cited by 641 · see citing works

The how’s and what’s of vaccine reactogenicity

Hervé, C., Laupèze, B., Giudice, G. D., Didierlaurent, A. M., & Silva, F. T. D. (2019) · npj Vaccines · doi:10.1038/s41541-019-0132-6 · Cited by 515 · see citing works

Immune-mediated approaches against COVID-19

Florindo, H. F., Kleiner, R., Vaskovich‐Koubi, D., Acúrcio, R. C., Carreira, B., Yeini, E., Tiram, G., Liubomirski, Y., & Satchi‐Fainaro, R. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0732-3 · Cited by 342 · see citing works

Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Pormohammad, A., Zarei, M., Ghorbani, S., Mohammadi, M., Razizadeh, M. H., Turner, D., & Turner, R. J. (2021) · Vaccines · doi:10.3390/vaccines9050467 · Cited by 339 · see citing works

How Efficacious Must a COVID-19 Coronavirus Vaccine be to Prevent or Stop an Epidemic by Itself

Bartsch, S. M., O’Shea, K. J., Ferguson, M. C., Bottazzi, M. E., Wedlock, P. T., Strych, U., McKinnell, J. A., Siegmund, S. S., Cox, S. N., Hotez, P. J., et al. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.06.011 · Cited by 328 · see citing works

Effects of Pandemic Outbreak on Economies: Evidence From Business History Context

Shang, Y., Li, H., & Zhang, R. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.632043 · Cited by 297 · see citing works

SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond

Bettini, E., & Locci, M. (2021) · Vaccines · doi:10.3390/vaccines9020147 · Cited by 283 · see citing works

Pre-existing immunity against Ad vectors

Fausther‐Bovendo, H., & Kobinger, G. P. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29594 · Cited by 277 · see citing works

Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans

Dickerman, B. A., Gerlovin, H., Madenci, A. L., Kurgansky, K. E., Ferolito, B. R., Muñiz, M. J. F., GAGNON, D. R., Gaziano, J. M., Cho, K., Casas, J. P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2115463 · Cited by 244 · see citing works

Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis

Sharif, N., Alzahrani, K. J., Ahmed, S. N., & Dey, S. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714170 · Cited by 230 · see citing works

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial

Halperin, S. A., Ye, L., MacKinnon‐Cameron, D., Smith, B. R., Cahn, P. E., Ruiz-Palacios, G. M., Ikram, A., Lanas, F. T., Guerrero, M. L., Navarro, S. R. M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02753-7 · Cited by 225 · see citing works

Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial

Ella, R., Reddy, S., Blackwelder, W., Potdar, V., Yadav, P., Sarangi, V., Aileni, V. K., Kanungo, S., Rai, S., Reddy, P., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02000-6 · Cited by 217 · see citing works

Novel adjuvants & delivery vehicles for vaccines development: a road ahead.

Mohan, T., Verma, P., & Rao, D. N. (2013) · Europe PMC (PubMed Central) · Cited by 199 · see citing works

A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19

Heidary, M., Kaviar, V. H., Shirani, M., Ghanavati, R., Motahar, M., Sholeh, M., Ghahramanpour, H., & Khoshnood, S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.927306 · Cited by 172 · see citing works

Potential therapeutic options for COVID-19: an update on current evidence

Niknam, Z., Jafari, A., Golchin, A., Pouya, F. D., Nemati, M., Rezaei–Tavirani, M., & Rasmi, Y. (2022) · European journal of medical research · doi:10.1186/s40001-021-00626-3 · Cited by 150 · see citing works

SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis

Velikova, T. V., & Georgiev, T. (2021) · Rheumatology International · doi:10.1007/s00296-021-04792-9 · Cited by 150 · see citing works

Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials

Yang, Z.-R., Jiang, Y.-W., Li, F.-X., Liu, D., Lin, T.-F., Zhao, Z.-Y., Wei, C., Jin, Q.-Y., Li, X.-M., Jia, Y.-X., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00390-1 · Cited by 138 · see citing works

Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19

Lim, W. W., Mak, L., Leung, G. M., Cowling, B. J., & Peiris, M. J. S. (2021) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00177-4 · Cited by 138 · see citing works

Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3

Fan, Y., Chan, K., & Hung, I. (2021) · Vaccines · doi:10.3390/vaccines9090989 · Cited by 108 · see citing works

COVID-19 Vaccines: An Overview of Different Platforms

Kudlay, D. A., & Svistunov, A. А. (2022) · Bioengineering · doi:10.3390/bioengineering9020072 · Cited by 79 · see citing works

Development and Applications of Viral Vectored Vaccines to Combat Zoonotic and Emerging Public Health Threats

Vrba, S. M., Kirk, N. M., Brisse, M. E., Liang, Y., & Ly, H. (2020) · Vaccines · doi:10.3390/vaccines8040680 · Cited by 76 · see citing works

Efficacy and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis

Ghazy, R. M., Ashmawy, R., Hamdy, N. A., Elhadi, Y. A. M., Reyad, O. A., el Malawany, D. H., Almaghraby, A. M., Shaaban, R., & Taha, S. H. N. (2022) · Vaccines · doi:10.3390/vaccines10030350 · Cited by 71 · see citing works

Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world

Chavda, V. P., Yao, Q., Vora, L. K., Apostolopoulos, V., Patel, C. A., Bezbaruah, R., Patel, A., & Chen, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.961198 · Cited by 62 · see citing works

Meta‐analysis: Key features, potentials and misunderstandings

Dekkers, O. M. (2018) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12153 · Cited by 56 · see citing works

A narrative review of emergency use authorization versus full FDA approval and its effect on COVID-19 vaccination hesitancy

Koritala, T., Hussain, A., Pleshkova, Y., Dondapati, L., Tirupathi, R., Rabaan, A. A., Mutair, A. S. A., Alhumaid, S., Al‐Tawfiq, J. A., & Kashyap, R. (2021) · Infezioni in Medicina · doi:10.53854/liim-2903-4 · Cited by 37 · see citing works

Effect of corticosteroid therapy on mortality in COVID‐19 patients—A systematic review and meta‐analysis

Patel, C. A., Parmar, K., Patel, D., Patel, S. P., Sheth, D. B., & Beladiya, J. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2386 · Cited by 33 · see citing works

Achieving and sustaining herd immunity to SARS-CoV-2

Bolotin, S., Wilson, S. E., & Murti, M. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.210892 · Cited by 19 · see citing works

The effect of herd immunity thresholds on willingness to vaccinate

Andersson, P. A., Tinghög, G., & Västfjäll, D. (2022) · Humanities and Social Sciences Communications · doi:10.1057/s41599-022-01257-7 · Cited by 8 · see citing works

Side Effects of Mixing Vaccines against COVID-19 Infection among Saudi Population

Alshahrani, M. M., & Alqahtani, A. (2022) · Vaccines · doi:10.3390/vaccines10040519 · Cited by 8 · see citing works

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom

Croda, J., & Ranzani, O. (2021) · Lancet. Infectious Diseases (Print) · doi:10.1016/s1473-3099(21)00696-4 · Cited by 5 · see citing works

The Safety and Efficacy of inactivated COVID-19 vaccination in couples undergoing assisted reproductive technology: A prospective cohort study

Yang, J., Yao, Y., Lv, X.-Y., Geng, L.-H., Wang, Y., Adu‐Gyamfi, E. A., Wang, X., Qian, Y., Chen, M.-X., Zhong, Z.-H., et al. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126635 · Cited by 51 · see citing works

Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024

Zhou, G., Dael, N., Verweij, S., Balafas, S., Mubarik, S., Oude Rengerink, K., Pasmooij, A. M. G., van Baarle, D., Mol, P. G. M., de Bock, G. H., et al. (2025) · European Respiratory Review · doi:10.1183/16000617.0222-2024 · Cited by 34 · see citing works

Vaccines and monoclonal antibodies: new tools for malaria control

Miura, K., Flores-García, Y., Long, C. A., & Zavala, F. P. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00071-23 · Cited by 33 · see citing works

COVID-19 Vaccination and Public Health: Addressing Global, Regional, and Within-Country Inequalities

Santangelo, O. E., Provenzano, S., Martino, G. D., & Ferrara, P. (2024) · Vaccines · doi:10.3390/vaccines12080885 · Cited by 32 · see citing works

Bioaerosols and Airborne Transmission in the Dental Clinic

Allison, J. R., Tiede, S., Holliday, R., Durham, J., & Jakubovics, N. S. (2024) · International Dental Journal · doi:10.1016/j.identj.2024.09.026 · Cited by 16 · see citing works

Comparison of antigen-specific B cell responses reveals disparity in immunogenicity and memory B cell formation across COVID-19 vaccine platforms

Guo, C. M., Chai, X., Baerlike, M., Liu, Y., Wang, Y., Shao, F., Huang, Q., Zhang, W., Cen, S., Dong, Y., et al. (2024) · hLife · doi:10.1016/j.hlife.2024.09.002 · Cited by 15 · see citing works

Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1/2/3 randomized clinical study

Ho, N. T., Smolenov, I. V., Tran, L. T. L., Nguyen, V. T., Ta, V. T., Nguyễn, T. V., Pham, H. N., Pham, A. T. V., Lương, Q. C., Chu, M. V., et al. (2025) · Expert Review of Vaccines · doi:10.1080/14760584.2025.2487542 · Cited by 14 · see citing works

Determinants of COVID-19 Vaccine Acceptance and Hesitancy: A Systematic Review

de Araújo, J. S. T., Delpino, F. M., Andrade, R. L. D. P., Aragão, F. B. A., Ferezin, L. P., Santos, D. A., Neto, N. C. D., do Nascimento, M. C., Moreira, S. R., Ribeiro, G. F., et al. (2024) · Vaccines · doi:10.3390/vaccines12121352 · Cited by 12 · see citing works

Network analysis of adverse event patterns following immunization with mRNA COVID-19 vaccines: real-world data from the European pharmacovigilance database EudraVigilance

Ferreira‐da‐Silva, R., Lobo, M. F., Pereira, A. M., Morato, M., Polónia, J. J., & Ribeiro‐Vaz, I. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1501921 · Cited by 11 · see citing works

A risk science perspective on the COVID-19 risk handling

Aven, T. (2024) · Journal of Risk Research · doi:10.1080/13669877.2024.2340019 · Cited by 7 · see citing works

D614G reshapes allosteric networks and opening mechanisms of SARS-CoV-2 spikes

Kearns, F. L., Bogetti, A. T., Calvó‐Tusell, C., Braza, M. K. E., Casalino, L., Gramm, A. J., Braet, S. M., Rosenfeld, M. A., Rajapaksha, H., Barker, B., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2504793123 · Cited by 7 · see citing works

Prevalence of menstrual alterations following COVID-19 vaccination: systematic review & meta-analysis

Shahrani, A. S. A., Alhumaidan, N. I., Alzelfawi, L., AlDosari, L., Alhindawi, Z., Alotaibi, N., & Aljohani, R. M. (2024) · BMC Women s Health · doi:10.1186/s12905-024-03349-9 · Cited by 7 · see citing works

COVID-19 vaccines: current and future challenges

Mohammadi, D., Ghasemi, M., Manouchehrian, N., Zafarmand, M., Akbari, M., & Boroumand, A. B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1434181 · Cited by 6 · see citing works

An mRNA Vaccine Expressing Blood-Stage Malaria Antigens Induces Complete Protection Against Lethal Plasmodium yoelii

Ott, A. C., Loll, P. J., & Burns, J. M. (2025) · Vaccines · doi:10.3390/vaccines13070702 · Cited by 6 · see citing works

Prioritization of Vaccines for Introduction in the National Immunization Program in the Republic of Korea

Choi, W. S., Sung, Y., Kim, J., Seok, H., Choe, Y. J., Cheong, C., Cho, J., Lee, D., Shin, J. Y., & Yu, S. (2024) · Vaccines · doi:10.3390/vaccines12080886 · Cited by 6 · see citing works

Broad-spectrum affinity chromatography of SARS-CoV-2 and Omicron vaccines from ligand screening to purification

Ma, J., Dong, X., Sun, Y. P., & Shi, Q. (2025) · Journal of Chromatography A · doi:10.1016/j.chroma.2025.465685 · Cited by 6 · see citing works

mRNA vaccines and therapeutics beyond COVID-19: A review of the global clinical development landscape, low- and middle-income countries involvement and relevance to their contexts

Moschioni, M., Siraji, R. A., Dissard, R., Segafredo, G., Mutungi, H., Jain, A., Thakur, R., Maurya, N., & James, I. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2628424 · Cited by 5 · see citing works

COVID-19 Vaccination and Vaccine Hesitancy in the Gaza Strip from a Cross-Sectional Survey in 2023: Prevalence, Risk Factors, and Associations with Health System Interventions

Majer, J., Elhissi, J. H., Mousa, N., John-Kall, J., & Kostandova, N. (2024) · Vaccines · doi:10.3390/vaccines12101098 · Cited by 4 · see citing works

Bicyclic peptide-enhanced covalent inhibitor of SARS-CoV-2 3CL protease

Wang, Q., Wang, Y., Li, J., Liu, H. S., & Chen, S. (2024) · Exploration of Drug Science · doi:10.37349/eds.2024.00071 · Cited by 4 · see citing works

Globally approved vaccines for COVID-19: a systematic review

Magalhães, B. D. A. P., Minasi, J. M., Lobato, R. C., Lemos, L. C., de Britto, L. S., Barros, R. M., de Martínez, A. M. B., & da Hora, V. P. (2025) · Brazilian Journal of Microbiology · doi:10.1007/s42770-024-01600-x · Cited by 4 · see citing works

COVID-19 Vaccination in Patients with Hematological Malignances

Franchini, M., Maggi, F., & Focosi, D. (2025) · Vaccines · doi:10.3390/vaccines13050465 · Cited by 4 · see citing works

Opting for the appropriate methodology for quantification of residual DNA impurities in mRNA vaccines

Vieths, S., Waibler, Z., & Schumann, G. G. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127186 · Cited by 4 · see citing works

Divergent origins, divergent pandemic potential: A comparative analysis of HMPV and SARS-CoV-2

Mozaffari, F., Fakhari, S., Elikaei, A., Ahmadi, Z., Farahmand, B., & Maleki, A. (2025) · Journal of Clinical Virology Plus · doi:10.1016/j.jcvp.2025.100223 · Cited by 4 · see citing works

Predictive factors of coronavirus disease (COVID-19) vaccination series completion: a one-year longitudinal web-based observational study in Japan

Kobayashi, T., Tokiya, M., Matsumoto, A., Nakano, T., Hirota, Y., & Hara, M. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1348170 · Cited by 3 · see citing works

Effective, but Safe? Physiologically Based Pharmacokinetic (PBPK)-Modeling-Based Dosing Study of Molnupiravir for Risk Assessment in Pediatric Subpopulations

Mishra, S., & Rox, K. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00535 · Cited by 3 · see citing works

Receiving three doses of inactivated or mRNA COVID-19 vaccines was associated with lower odds of long COVID symptoms among people with a history of SARS-CoV-2 infection in Hong Kong, China: a cross-sectional survey study

Zheng, C., Yu, F.-Y., Chan, P. S.-F., Sun, F., Chen, X., Huang, Y., Wong, S. H., Fang, Y., & Wang, Z. J. (2024) · Epidemiology and Infection · doi:10.1017/s0950268824001687 · Cited by 3 · see citing works

Musculoskeletal Complications in COVID-19: Exploring the Role of Key Biomarkers

Patel, S., Foster, C., Patel, K., Hunter, M., Isales, C. M., & Fulzele, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178569 · Cited by 3 · see citing works

Recent Advances in Designing Adeno-Associated Virus-Based Vaccines Against Viral Infections

Mnyandu, N., Jacobs, R., Arbuthnot, P. B., & Maepa, M. B. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16111360 · Cited by 3 · see citing works

Hypericin Suppresses SARS-CoV-2 Replication and Synergizes with Antivirals via Dual Targeting of RdRp and 3CLpro

Souza, H. D. S., Martins, J. S. C. C., Sousa, T. D. C., Sardar, S., Rodrigues, N. F., Silva-Trujillo, L., Souza, T. M. L., Siqueira, M. M., Fernández, J. H., & Matos, A. D. R. (2025) · Microorganisms · doi:10.3390/microorganisms13051004 · Cited by 2 · see citing works

Antiseptics as effective virucidal agents against SARS-CoV-2: Systematic review and Bayesian network meta-analysis

Seijas‐Otero, N., Blanco‐Pintos, T., Regueira‐Iglesias, A., Suárez‐Rodríguez, B., Sánchez‐Barco, A., Balsa‐Castro, C., & Tomás, I. (2025) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2025.05.001 · Cited by 2 · see citing works

The Effectiveness and Influence of COVID‐19 Vaccination on Perinatal Individuals and Their Newborns: An Updated Meta‐Analysis

Lei, Z.-J., Bai, M.-X., Li, M., Jin, P., & Ding, Y. (2025) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/cjid/6115890 · Cited by 2 · see citing works

Comparison of the rates of emergent otologic adverse events following mRNA COVID-19 versus influenza vaccination: a matched cohort analysis

Munjal, T., Batts, S. A., Gombar, S., & Stanković, K. M. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1637870 · Cited by 2 · see citing works

In Silico Design of miniACE2 Decoys with In Vitro Enhanced Neutralization Activity against SARS-CoV-2, Encompassing Omicron Subvariants

Romero, J. A. A., López-Cantillo, G., Moreno-Jiménez, S., Marcos‐Alcalde, Í., Ros‐Pardo, D., Camacho, B., Gómez‐Puertas, P., & Ramirez-Segura, C. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910802 · Cited by 2 · see citing works

Aplastic Anemia in the light of the COVID-19 pandemic: infection, vaccination, and pathophysiologic mechanisms

Cahuapaza-Gutierrez, N. L. (2024) · Annals of Hematology · doi:10.1007/s00277-024-06052-9 · Cited by 2 · see citing works

Distinct response patterns of endothelial markers to the BNT162b2 mRNA COVID-19 booster vaccine are associated with the spike-specific IgG antibody production

Castro‐Robles, B., Cimas, F. J., Arias-Salazar, L., Ontañón, J., Lozano, J., López‐López, S., Pretel, F. A., Requena-Calleja, M.-Á., Más, A., Serrano‐Heras, G., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1471401 · Cited by 2 · see citing works

The relationship between vaccination and uveitis: A comprehensive review of immune response, risk assessment, and clinical implications

Zhang, Y., Tao, T., Li, Z., Li, H., Jiang, Q., Zhu, L., & Su, W. (2025) · Eye & ENT Research · doi:10.1002/eer3.70000 · Cited by 2 · see citing works

Real-world Evaluation of the Effectiveness of Sinopharm COVID-19 Vaccine Against Symptomatic COVID-19 in an Omicron-Dominant Setting in Mozambique: A Test-Negative, Case-Control Study

Capitine, I. P. U., Aziz, A. B., Manhiça, A., Tivane, I., Zumba, A., Nhumba, M., Rebocho, Z., Miquicene, E., Nguenha, N. M. C., Langa, J. P., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf093 · Cited by 2 · see citing works

Vaccination against a COVID-19 and predictors of COVID-19 development in patients after heart transplantation: a Russian multicenter observational study

Simonenko, M., Федотов, П. А., Kostomarov, A. N., Kosmacheva, E. D., Kolodina, M. V., Utmanova, I. V., Головина, Т. С., Melnikov, I. Y., Зубарева, И. Г., Gorbunova, N. A., et al. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-6067 · Cited by 1 · see citing works

The 3rd anniversary of Frontiers in Virology: aiming to consolidate the virus research

Adachi, A., Koma, T., & Nomaguchi, M. (2024) · Frontiers in Virology · doi:10.3389/fviro.2024.1505809 · Cited by 1 · see citing works

World Pneumonia Day: Why Do We Still Need It?

Bush, A., & WATERER, G. W. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202410-1883vp · Cited by 1 · see citing works

COVID-19 Vaccination and Transient Increase in CD4/CD8 Cell Counts in People with HIV: Evidence from China

Li, Y., Lin, Y., Yi, Y., Zhu, N., Cui, X., & Li, X. (2024) · Vaccines · doi:10.3390/vaccines12121365 · Cited by 1 · see citing works

Integrating mRNA vaccines into the attitudes toward genomics and precision medicine scale: A validation study with a sample of 4939 adults in the USA

Harris, J. K., Solomon, E. D., Baldwin, K. A., Baker, L. L., Chin, E. G., & DuBois, J. M. (2025) · Journal of Clinical and Translational Science · doi:10.1017/cts.2025.38 · Cited by 1 · see citing works

Kikuchi-Fujimoto in the light of the COVID-19: infection and vaccination. A systematic review

Cahuapaza-Gutierrez, N. L., Calderon-Hernandez, C. C., & Villavicencio-Escudero, T. V. (2025) · Clinical Rheumatology · doi:10.1007/s10067-025-07548-z · Cited by 1 · see citing works

Factors influencing COVID-19 vaccine uptake among vulnerable communities in Texas: Perceptions of 2-1-1 helpline callers

Savas, L. S., Cuccaro, P. M., Zhang, K., Hernandez, R., Haffey, M. E., Reininger, B. M., Mendiola, A., Dominguez, O., Sifuentes, M. R., Bauer, C., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127554 · Cited by 1 · see citing works

Post-COVID-19 Rehabilitation Improves Mobility and Gait Performance: Evidence from TUG and 10MWT

Chiriac, O. C., Miricescu, D., Sporea, C., Stanciu, S. M., Luncă, D.-C., Bădoiu, S. C., Văcăroiu, I. A., Mititelu, R., Grigore, R., Mitrea, A. R., et al. (2025) · Healthcare · doi:10.3390/healthcare13222892 · Cited by 1 · see citing works

Effectiveness, Comparative Effectiveness, and Harms of COVID-19 Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians

Dobrescu, A. I., Pinte, L., Sharifan, A., Gadinger, A., Moser, I., Cooper, C., & Gartlehner, G. (2026) · Annals of Internal Medicine · doi:10.7326/annals-25-05044 · Cited by 1 · see citing works

Autoimmunity following SARS-CoV-2 infection and vaccination: Systematic review and meta-analysis

Anouar, O., Elghali, M., Zanina, Y., Changuel, M., & Sakly, N. (2026) · Clinical Immunology · doi:10.1016/j.clim.2026.110702 · Cited by 1 · see citing works

From legacy to innovation: A comprehensive review of vaccine platforms against viral infections

Farsiu, N., Mahani, F. K., Arefinia, N., Charostad, J., Pardeshenas, M., Mirzaei, H., Nakhaie, M., Hassandarvish, P., & AbuBakar, S. (2026) · Virus Research · doi:10.1016/j.virusres.2026.199730 · Cited by 1 · see citing works

In vitro antibody-mediated SARS-CoV-2 infection suppression through human ACE2 receptor blockade

Redd, P. S., Merting, A. D., Klement, J. D., Poschel, D. B., Yang, D.-F., & Liu, K.-B. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106887 · Cited by 1 · see citing works

Authors' Response: Safety and Efficacy of COVID‐19 Vaccines: A Systematic Review and Meta‐Analysis of Controlled and Randomized Clinical Trials

Beladiya, J., Kumar, A., Vasava, Y., Parmar, K., Patel, D., Patel, S., Dholakia, S. P., Sheth, D. B., Boddu, S. H. S., & Patel, C. A. (2024) · Reviews in Medical Virology · doi:10.1002/rmv.2573 · Cited by 1 · see citing works

Tortured confessions? Potentially erroneous statistical inferences may underpin misleading claims of harms in reanalyses of COVID-19 and HPV vaccines

Grimes, D. R. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126657 · Cited by 1 · see citing works

Retrospective Clinical Investigation into the Association Between Abnormal Blood Clotting, Oral Anticoagulant Therapy, and Medium-Term Mortality in a Cohort of COVID-19 Patients

Dinoi, G., Togo, M. V., Guida, P., Deruvo, C., Samarelli, F., Imbrici, P., Nicolotti, O., Luca, A. D., Mastroianni, F., Liantonio, A., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13030535 · Cited by 1 · see citing works

Mandatory vaccination against COVID-19 and Influenza for ICU personnel? Yes!

Langbeen, J., Vogelaers, D., & Blot, S. I. (2025) · Intensive and Critical Care Nursing · doi:10.1016/j.iccn.2025.104082 · Cited by 1 · see citing works

Case fatality rate and determinants of maternal death among pregnant women with SARS-CoV-2 infection: A population-based cohort study in Bahia, Brazil

Carvalho-Sauer, R., Costa, M. D. C. N., Flores-Ortiz, R., Teixeira, M. G., & Paixão, E. S. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.108144 · Cited by 1 · see citing works

Challenges and opportunities in the face of Mpox in Latin America

Cubides-Díaz, D. A., & Álvarez, C. (2024) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361241292627 · Cited by 1 · see citing works

Anti-COVID-19 Vaccination in the Italian General Population: Proactive Clinical Risk Analysis Using Failure Mode, Effects, and Criticality Analysis Technique

Balestracci, B., Candido, G., Federici, L., Parretti, C., Tartaglia, R., Lachman, P. I., Bianco, A., & Regina, M. L. (2024) · Healthcare · doi:10.3390/healthcare12242541

Association between demographic, clinical characteristics and severe complications by SARS-CoV-2 infection in a community-based healthcare network in Chile

Léniz, J., Hernández-Jaña, S., Soto, M., Arenas, E., Margozzini, P., Suarez, F., Daniel Capurro, N., Rojas, M. P., & Claudia Bambs, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0314376

Assessing the effectiveness of vaccination strategies against respiratory pathogens

Abdullah, M. Y., Alanazi, F. M., Gandurah, S. F., Altufayif, D. A., Alghamdi, A. M., Halawani, O. A., Almudarhem, F. F., Al-Otaibe, R. I., Allathiqani, O. M., & Alasmari, A. A. (2025) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20250065

Longitudinal Assessment of Pulmonary Involvement and Prognosis in Different Subtypes of COVID-19 Patients After One Year Using Low-Dose CT: A Prospective Observational Study

Zhao, J., Dong, L., Jiao, X., Xia, F., Shan, Q., Tang, J., Wang, S., & Lyu, X. (2025) · Academic Radiology · doi:10.1016/j.acra.2025.01.006

Vaccination against the SARS-CoV-2 in individuals with comorbidities

Berns, S. A., Chashchin, M. G., Gorshkov, A. Y., Zhdanova, O. V., Ryzhakova, L. N., Litinskaya, O. A., & Drapkina, O. M. (2015) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-4284

Modèles précliniques in vitro reproduisant l’épithélium respiratoire : application à l’étude de l’infection par le virus SARS-CoV-2

Morichon, L., Assou, S., BOURDIN, A. A., Muriaux, D. M., & Vos, J. D. (2025) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2025.02.001

Monitoring humoral immune response following COVID-19 immunization and booster dose: A prospective study in tunisian healthcare workers

Naffouti, C., Hannachi, H., Aissi, W., Ayari, I., Salem, F. B., Hamdoun, M., & Bahri, O. (2025) · Journal of Clinical Virology Plus · doi:10.1016/j.jcvp.2025.100210

Effects of COVID-19 vaccination and past SARS-CoV-2 infection on subsequent COVID-19 infection in people with HIV

Yang, X., Shi, F., Chen, S., Liu, Z., Xu, Y., Poland, G. A., Weissman, S., Olatosi, B., Zhang, J., & Li, X. (2025) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2025.05.005

Adverse Events and Associated Economic Burden of COVID-19 Vaccination in Queensland, Australia: Findings from the Cross-Sectional QoVAX-Statewide Study

Xia, Q., O’Grady, K.-A. F., Vardon, P., Ward, S. R., Gregory, R., Davies, J. M., & Carter, H. E. (2025) · Vaccines · doi:10.3390/vaccines13070712

Nirmatrelvir-Ritonavir Access and Hospitalizations and Mortality in Older Adults

Hao, W. (2025) · JAMA · doi:10.1001/jama.2025.6488

VacSafe: Protocol for an observational cohort surveillance programme to assess maternal and neonatal outcomes from three sites in The Gambia, 2022-2024Preprint

Okomo, U. A., Longley, A. T., Nkereuwem, O., Kochhar, S., Shaum, A., Gidudu, J., & Kampmann, B. (2025) · doi:10.12688/verixiv.1343.1

RFK Jr’s shakeup of vaccine advisory committee raises worries about scientific integrity of health recommendations

Gautam, S. (2025) · doi:10.64628/aai.vqspd7c36

Estimated SARS-CoV-2 Seroprevalence Among Children: United States, September 2021 to December 2022

Bratcher, A. M., Deng, Y., Deng, X., Kim, Y., Coughlin, M. M., Hagen, M. B., Hall, A. J., Swanson, B. E., Meyer, W. A., Gundlapalli, A. V., et al. (2025) · Pediatrics Open Science · doi:10.1542/pedsos.2024-000441

Update: Respiratorische Viren – SARS-CoV-2, respiratorisches Synzytialvirus, Influenza‑, Rhino-, humanes Metapneumo- und Bocavirus

Csernalabics, B., Boos, K., & Mayer, K. (2025) · Zeitschrift für Pneumologie · doi:10.1007/s10405-025-00639-3

Long-term effectiveness of COVID-19 vaccination in preventing hospitalization among household contacts: A case–control study from December 2021 to April 2023

Zhang, L., Liu, D., Cao, X., Zhang, H., Li, S., Wang, R., Mu, Y., Han, M., Wang, Y., & Cao, B. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2563760

Gut-initiated mucosal and systemic immunity against SARS-CoV-2 via an oral hyaluronic acid/chitosan vaccine coacervate

Li, S., Huo, S., Zheng, W., Wu, S., Chen, Y., Zhang, Z., Wang, B., Zhao, Z., Huo, N., Xu, J., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114376

Menstrual cycle phase and its association with COVID-19 vaccine side effects and subsequent infection: A study of period tracking app usersPreprint

Cooper, P. A., Boniface, E. R., Darney, B. G., Edelman, A. B., Sear, R., Shea, A. A., Walters, S., Weber, K., Vitzthum, V. J., & Alvergne, A. (2025) · medRxiv · doi:10.1101/2025.11.26.25341088

Endocrine disorders following SARS-CoV-2 vaccination: a comprehensive systematic review

Calderon-Hernandez, C. C., Cahuapaza-Gutierrez, N. L., Villavicencio-Escudero, T. V., Ibárcena-Llerena, C. V., Quiroz-Narvaez, C., Coronado-Quispe, H. Y., & Chapoñan-Agip, N. V. (2025) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2026.15.e6

In Silico Exploration of Potential Inhibitors Targeting SARS ‐ CoV ‐2 Non‐Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research

Yazdani, B., Sirous, H., Farzam, F., Ansarizadeh, S., Taheri, M. K., Pourmohammad‐Hosseini, G., Masjedi, M. N.-K., Daneshipour, K., Shakeri, D., Houshangi, M., et al. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70218

Vaccination in the post-COVID era: lessons to be learned in Latin America

Carpio-Orantes, L. D., & Zambrano-Sánchez, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1726836

Association Between Antenatal COVID-19 Vaccination and Neonatal Outcomes

Thewaran, N., Laohavinij, W., Chaithongwongwatthana, S., Woratanarat, P., Lohsoonthorn, V., & Woratanarat, T. (2025) · Journal of Patient Safety · doi:10.1097/pts.0000000000001446

VACCINE PREPARATIONS - FROM DEVELOPMENT TO CLINICAL TRIALS

Zhapbar, A. P., Mamadaliev, S. M., Nissanova, R. K., Башенова, Э., Акшалова, П. Б., Маманова, С., Akmyrzaev, N. Z., Bizhanov, A. B., Nurpeisova, A. S., & KASSENOV, M. M. (2025) · МИКРОБИОЛОГИЯ ЖӘНЕ ВИРУСОЛОГИЯ · doi:10.53729/mv-as.2025.04.03

COVID-19 Pandemic and Next Pandemic Preparedness of Long-term Care Hospitals and Facilities

Chang, K. (2025) · Korean Journal of Healthcare-Associated Infection Control and Prevention · doi:10.14192/kjicp.2025.30.2.105

SARS-CoV-2: A Comprehensive Insight into DNA, RNA, Subunit, and Viral Vaccines

Tabassum, S. (2025) · Medical virology · doi:10.1007/978-981-95-1426-7_18

Knowledge and attitudes of Bahraini citizens regarding the safety and efficacy of the coronavirus disease 2019 vaccines—A cross-sectional study

AlAani, K. M., Abdulla, L. A., Almajed, A., Mohroofi, A. D. M., Almutawa, A. E., Alnajdi, M. H., Alghawi, S. S., Alqallaf, S. M., & Alroomi, K. (2026) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1799_25

Validation of CURB-65, CRB-65, NEWS2, qSOFA, and 4C scores for predicting mortality in COVID-19 patients across seven emergency Departments in Colombia

Valderrama, S., Cuervo-Rojas, J., Rondón, M., Martínez-Vernaza, S., Siegler, I. H. D. L. H., Rodriguez-Morales, A. J., Cañas-Arboleda, A., Múñoz, Ó., Padilla, M., Mesa-Rubio, M. L., et al. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1738978

Decline in habitual exercise after total hip arthroplasty during the COVID-19 pandemic: Who was most at risk?

Inoue, T., Hamai, S., Konishi, T., Kawahara, S., Motomura, G., Yamaguchi, R., Utsunomiya, T., Kitamura, K., Yoshino, S., Yamate, S., et al. (2026) · Journal of Orthopaedic Science · doi:10.1016/j.jos.2026.01.012

Predicting cardiovascular and neurological complications after COVID-19 vaccination: Insights from a comprehensive review

Sannathimmappa, M. B., Nambiar, V., & Satti, S. (2026) · Scientific African · doi:10.1016/j.sciaf.2026.e03269

Evaluación de la inmunidad híbrida y comorbilidades en el sector educativo de México: perspectivas de la vacunación con Cansino/Moderna contra el SARS-CoV-2

Pérez-Lara, J. C., Díaz-Vallejo, J. J., Casiano, J. O. H., & Gallardo-Hernández, C. A. (2025) · Revista de Salud Pública · doi:10.15446/rsap.v27n3.117724

Adapting covid-19 vaccination through targeted approaches: FDA-approved vaccines for the 2025–2026 season

Begum, R. F., Mathew, M., Doshi, P. P., & Suresh, S. (2026) · Immunologic Research · doi:10.1007/s12026-026-09757-3

COVID-19 and Solid Organ Transplantation: What We Learned and Where We are Going

Huang, J., & Pouch, S. M. (2026) · Current Infectious Disease Reports · doi:10.1007/s11908-026-00881-7

COVID-19 Vaccine Effectiveness in Individuals with Alcohol and Tobacco Use Disorders: A Propensity Score-Matched Study Using Nationwide Brazilian Data

Oliveira, F. E. S., Martelli, D. R. B., Oliveira, M. A. S., Colosimo, E. A., Silva, A. C. S. E., Andrade, A. L. O., Herrerias, R. R., Foligno, L. R. C., Barbosa, I. O., Júnior, H. M., et al. (2026) · Vaccines · doi:10.3390/vaccines14050376

The impact of COVID-19 vaccination on long-term risk of new-onset atrial fibrillation/flutter after COVID-19 infection: A retrospective cohort study

Ko, C.-C., Wu, J.-Y., Hung, K., Liao, S.-W., Tsai, Y., Yu, T., Lin, C.-M., & Chen, I. (2026) · PLoS ONE · doi:10.1371/journal.pone.0348133

Keeping Vaccine Recommendations Evidence-Based and Patient-Centered

Ahasic, A. M., & Frye, L. K. (2026) · CHEST Journal · doi:10.1016/j.chest.2025.11.018

Impact and assessment of nutritional status in patients undergoing treatment for colorectal cancer

Filipović, T., Perić, D., & Jovanović, N. (2026) · Timocki medicinski glasnik · doi:10.5937/tmg2601010f

Health workforce models in the rolling out of COVID-19 vaccination during the pandemic: A rapid systematic review

Olson, K., Pratt, C., Nabia, S., Wonodi, C. B., Vilajeliu, A., Vega, V., Twose, C., Njiro, B. J., Suasti, A., Nduka, C. C., et al. (2026) · SSM - Health Systems · doi:10.1016/j.ssmhs.2026.100242

Liver injury after COVID-19 vaccination: Current status and future perspectives

Sato, K. (2026) · World Journal of Hepatology · doi:10.4254/wjh.v18.i5.116542

Fasciculations Following COVID-19 Vaccination—A Case Series of Ten Patients

Breuer, A., Raeder, V., Pernice, H. F., Boesl, F., Prüß, H., Audebert, H. J., Hahn, K., & Franke, C. (2026) · Vaccines · doi:10.3390/vaccines14060541

Önem Kazanan Solunum Yolu Virüsleri ve Güncel Gelişmeler

Özdemir, E., & Kazak, E. (2026) · Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi · doi:10.17517/ksutfd.1623445

The potential public health consequences of “mRNA vaccine stigmatization” in the US

Motta, M. (2026) · Politics and the Life Sciences · doi:10.1017/pls.2026.10027

Navigating the Transition to RNA-Based Influenza Vaccines: A State-of-the-Art Review

Panagiotopoulos, A.-P., Tsakri, D., Laskaris, A., Saldari, C., Ranellou, K., Mariolis, I., Tsakris, A., & Anastassopoulou, C. G. (2026) · Vaccines · doi:10.3390/vaccines14100874

Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis

Sharif, N., Alzahrani, K. J., Ahmed, S. N., & Dey, S. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714170 · Cited by 230 · see citing works

Efficacy and Safety of mRNA based COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical TrialsPreprint

Chaudhary, N., Ahuja, R., Sherwani, A., & Chauhan, S. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4254949 · Cited by 1 · see citing works

Are Vaccines Effective and Safe for the Prevention of COVID-19 Infections? A Living Systematic Review

Lapitan, M. C., Besa, J. J. V., Dans, L. F., Tolosa, M. T. S., & Alejandria, M. M. (2021) · Acta Medica Philippina · doi:10.47895/amp.v55i2.2875 · Cited by 4 · see citing works

Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical TrialsPreprint

Pormohammad, A., Zarei, M., Ghorbani, S., Mohammadi, M., Razizadeh, M. H., & Turner, R. J. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3812422 · Cited by 59 · see citing works

IMMUNOGENICITY, SAFETY, AND EFFICACY OF COVID-19 VACCINES: A SYSTEMATIC REVIEW OF THE LITERATURE

Tarik Chmitah*1, S. F. (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.23117664